Recent advances demonstrate a critical yet poorly understood role for the pancreatic stellate cell (PSC) in the pathogenesis of chronic pancreatitis (CP) and pancreatic cancer (PC). Progress in this area has been hampered by the availability, fidelity, and/or reliability of in vitro models of PSCs. We examined whether outgrowth cultures from human surgical specimens exhibited reproducible phenotypic and functional characteristics of PSCs. PSCs were cultured from surgical specimens of healthy pancreas, CP and PC. Growth dynamics, phenotypic characteristics, soluble mediator secretion profiles and co-culture with PC cells both in vitro and in vivo were assessed. Forty-seven primary cultures were established from 52 attempts, demonstrating universal α-smooth muscle actin and glial fibrillary acidic protein but negligible epithelial surface antigen expression. Modification of culture conditions consistently led to cytoplasmic lipid accumulation, suggesting induction of a quiescent phenotype. Secretion of growth factors, chemokines and cytokines did not significantly differ between donor pathologies, but did evolve over time in culture. Co-culture of PSCs with established PC cell lines resulted in significant changes in levels of multiple secreted mediators. Primary PSCs co-inoculated with PC cells in a xenograft model led to augmented tumor growth and metastasis. Therefore, regardless of donor pathology, outgrowth cultures produce PSCs that demonstrate consistent growth and protein secretion properties. Primary cultures from pancreatic surgical specimens, including malignancies, may represent a reliable source of human PSCs. Evidence continues to accumulate implicating the intense desmoplastic reaction common to both chronic pancreatitis (CP) and pancreatic cancer (PC) is not simply a bystander process from a dynamic inflammatory state, but rather represents a complex interplay within the microenvironment responsible for the initiation and maintenance of key pathologic feedback systems. 1 Pancreatic stellate cells (PSCs) appear to represent a critical determinant in the development and maintenance of this desmoplastic microenvironment in pancreatic disease states. 2-4 However, recent investigations have questioned the role of PSCs in cancer. Specifically, depletion of activated PSCs in genetically engineered mouse models of PC has paradoxically demonstrated pro-tumor effects. 5, 6 While disparate from prior observations showing the tumor promoting abilities of activated PSCs, 3,7-9 these investigations still implicate an interplay between PSCs, other cells within the tumor microenvironment, and the cancer. 5, 6 Given these disparate findings, further investigation into the biology of PSCs in various disease states is essential and necessitates a high degree of experimental standardization. To this effect, an expert panel recently published guidelines regarding PSC isolation, identification, and activation. 10 Human PSCs are most typically isolated via the outgrowth method, whereby direct culture of minced pancreatic specimens yields activated PSCs with limited replicative potential. [11] [12] [13] This approach remains a vital experimental model strategy for human PSCs as immortalization imparts significant genetic instability. 10 However, owing to the surgical specialization required and relative infrequency of pancreatic operations, centers investigating PSC biology are often unable to achieve sufficient human specimens to consistently and reliably generate primary cultures. Further, pancreatic resections are performed for a diverse array of pathologies, but most typically are performed for malignancy. Whether the particular pathology necessitating resection imparts physiologic changes
Evidence continues to accumulate implicating the intense desmoplastic reaction common to both chronic pancreatitis (CP) and pancreatic cancer (PC) is not simply a bystander process from a dynamic inflammatory state, but rather represents a complex interplay within the microenvironment responsible for the initiation and maintenance of key pathologic feedback systems. 1 Pancreatic stellate cells (PSCs) appear to represent a critical determinant in the development and maintenance of this desmoplastic microenvironment in pancreatic disease states. [2] [3] [4] However, recent investigations have questioned the role of PSCs in cancer. Specifically, depletion of activated PSCs in genetically engineered mouse models of PC has paradoxically demonstrated pro-tumor effects. 5, 6 While disparate from prior observations showing the tumor promoting abilities of activated PSCs, 3, [7] [8] [9] these investigations still implicate an interplay between PSCs, other cells within the tumor microenvironment, and the cancer. 5, 6 Given these disparate findings, further investigation into the biology of PSCs in various disease states is essential and necessitates a high degree of experimental standardization. To this effect, an expert panel recently published guidelines regarding PSC isolation, identification, and activation. 10 Human PSCs are most typically isolated via the outgrowth method, whereby direct culture of minced pancreatic specimens yields activated PSCs with limited replicative potential. [11] [12] [13] This approach remains a vital experimental model strategy for human PSCs as immortalization imparts significant genetic instability. 10 However, owing to the surgical specialization required and relative infrequency of pancreatic operations, centers investigating PSC biology are often unable to achieve sufficient human specimens to consistently and reliably generate primary cultures. Further, pancreatic resections are performed for a diverse array of pathologies, but most typically are performed for malignancy. Whether the particular pathology necessitating resection imparts physiologic changes that persist in PSC outgrowth cultures, represents a fundamental scientific question with direct implications for further investigations into PSC biology.
Taken together, these issues highlight the translational value in defining PSC biology with respect to the pathogenesis of pancreatic disease. We report the successful culture and characterization of human PSCs primary cultures from 47 pancreatic specimens, supporting outgrowth cultures as an efficient, high-throughput, reproducible, isolation technique for human PSCs. Our characterization was based on consensus guidelines in a cohort of outgrowths representing a range of pancreatic pathologies. 10 As PSC biology is often investigated in the context of paracrine signaling leading to inflammation and/or cancer progression, PSC soluble mediator secretion profiles were evaluated in culture with respect to donor pathology and extent of passage. Further, consistent changes in secretion profiles with PC cell co-culture were demonstrated as well as functional augmentation of tumor growth and metastasis of co-inoculated PSC/PC cells in a murine xenograft model.
MATERIALS AND METHODS Cell Lines and Reagents
Human PC cell lines BxPC3 and PANC-1 were obtained from American Type Culture Collection (Rockville, MD, USA) and were used within 6 months and authenticated by STR analysis. The metastatic PC cell line L3.6pl was derived as previously described. 14, 15 The human fetal primary pancreatic fibroblast (HPF) cell line was purchased from Vitro Biopharma (Golden, CO, USA). Growth characteristics of HPF cells have been validated and publicized by the manufacturer. Cells were maintained in culture with Dulbecco's Modified Eagle's Medium-F12 (DMEM-F12), 10% fetal bovine serum (FBS) (Atlanta Biologicals, Atlanta, GA, USA), antibiotic antimycotic solution (Fisher Scientific, Waltham, MA, USA) and 5% CO 2 at 37°C.
Isolation and Culture of Human Pancreatic Stromal Outgrowths
Primary PSCs were isolated from fresh pancreatic surgical specimens under an institutional review board approved protocol. Informed consent was obtained from all patients preoperatively. Fresh tissues were obtained in complete culture medium on ice within 30 min of operative resection. Tissue fragments were then dissected into~1 mm 3 pieces and six-eight pieces were placed in each well of a six-well plate pre-coated with 10 mM CaCl 2 /FBS. Cells were passaged at a density of 2.5 × 10 5 cells per 100 mm dish and grown to 80% confluence. Cell counts were determined using the TX20 (Bio-Rad Laboratories, Hercules, CA, USA). Population doubling levels (PDL) were calculated using the formula: PDL = 3.32 × (logX e -logX b )+S × X b where X b and X e represent cell numbers at the beginning and end of the incubation time.
Flow Cytometry Analysis
Primary PSCs were fixed, permeabilized, and stained with primary antibodies, including anti-α-smooth muscle actin (SMA)-AF488 (R&D systems, Minneapolis, MN, USA), anti-epithelial surface antigen (ESA)-phycoeryrthrin (PE) (Miltenyi Biotec, San Diego, CA, USA), or anti-glial fibrillary acidic protein (GFAP) (Dako, Carpinteria, CA, USA) with anti-rabbit IgG-AF488 (Invitrogen, Carlsbad, CA, USA). Dual staining for anti-Ki67-FITC (BD Biosciences, San Jose, CA, USA) and anti-γ-H2A-AF647 (Cell Signaling) was used for assessing senescence. Flow cytometric analysis employed the LSRII flow cytometer and data were analyzed with FACSDiva software (BD Biosciences).
Fluorescence-Activated Cell Sorting
To further characterize the ESA dim PSCs, PSCs were labeled with PE conjugated anti-ESA antibody and cell sorting was performed using the FACS Aria-II (BD Biosciences). The PE signal was collected in the FL1 channel through a 575/25 bandpass filter. Cells were displayed in a single-parameter histogram and ESA-PE dim PSCs were collected in DMEM-F12 with 10% FBS.
Immunofluorescence Cells cultured on glass slides were fixed and permeablized with cold methanol/acetone solution (1:1) at − 20°C for 5 min. Antibodies for specific markers included: anti-α-SMA (SigmaAldrich, St. Louis, MO, USA), anti-GFAP (Dako, Carpinteria, CA, USA), and anti-ESA (Abcam, Cambridge, England). Secondary Alexa Fluor 488 conjugated anti-mouse or antirabbit IgG (Life Technologies, Carlsbad, CA, USA) were then applied. Acti-stain 488 was purchased from Cytoskeleton. Imaging was performed using the Olympus IX81-DSU Spinning Disk confocal microscope (Olympus Corporation, Tokyo, Japan).
Co-Culture Model
Early passage (P2-3) normal-associated stroma (NAS) lines were co-cultured with PC cell lines at a ratio of 10:1 PSC:PC cells for 24 h. Each PC cell line was co-cultured separately with each NAS line. Cells were given 24 h to adhere before experimentation. Control groups consisted of equivalent cell numbers of either PSCs or PC cells alone.
Analysis of Soluble Mediator Secretion
Supernatants of cultured PSC, PC cell lines, and co-cultures were collected after 24 h of serum starvation. Supernatants were then probed for soluble mediators using the Milliplex Premixed 41-Plex Immunology Multiplex Assay (Merck Millipore, Darmstadt, Germany). Concentrations were quantified using a standard curve and five parameter logistics to determine pg/ml concentrations. All samples were batch run in duplicate.
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Oil Red Staining Confluent cells were exposed to adipogenesis differentiation medium (DMEM-F12 medium supplemented with dexamethasone 1 μM, pantothenate 17 μM, and human recombinant insulin 1 μM) for 3 weeks. 16 Cells were then fixed in 10% neutral buffered formaldehyde for 30 min, washed in distilled water and stained using 60% oil red O (Sigma) solution for 15 min. Images were acquired by the EVOS Cell Imaging System. 
Animal Experiments
All in vivo studies were approved by the Institutional Animal Care and Use Committee of the University of Florida. Primary tumor-associated stroma (TAS) cells (10 5 cells) were co-injected with luciferase-transfected L3.6pl (10 3 cells) into the flanks of NOD-SCID mice (Jackson Laboratories, Bar Harbor, ME, USA). Bioluminescence imaging was performed each week and intensities recorded. Animals were euthanized once tumors reached 1.5 cm in size as measured by calipers. Tumor volume was calculated using the formula v = x 2 y/2, where x is the minimal and y is the maximal tumor dimension.
Statistical Analysis
Data were analyzed using the GraphPad Prism version 6.0. Normality was assessed using the Shapiro-Wilk test. Owing to the nonparametric nature of data, the MannWhitney U-test was used for comparisons between two groups, and the Kruskal-Wallis test was used for comparisons between three groups. Differences were considered significant at Po0.05.
RESULTS

Stromal Outgrowth Cultures from Pancreatic Surgical Specimens
Stromal outgrowth cultures were attempted from 51 pancreatic surgical specimens. Pathologies were broadly categorized into TAS from PC specimens, inflammation-associated stroma (IAS) from donors with CP, and NAS from nonmalignant pancreatic tissue without histologic evidence of chronic inflammation or other pathology. The majority of patients in the NAS category underwent pancreatic resection for either benign cystic lesions or duodenal adenomas. Pathologic categorization was confirmed by H&E analysis of immediately adjacent tissue ( Figure 1a ) and cross-referenced against final clinical diagnosis for each specimen. Immunohistochemical analysis of paraffin-embedded tissue sections revealed a preponderance of α-SMA-positive cells in both pancreatitis and ductal adenocarcinoma samples, while normal pancreatic specimens exhibited a relative scarcity of α-SMA-positive cells (Figure 1b) .
Within 3-4 weeks of initial culture, identifiable stellateshaped cells began to migrate from central tissue cores, progressively forming a homogenous monolayer (Figure 1c) . In this manner, successful outgrowth from 97.4% (37/38) of PC specimens, 87.5% (7/8) of CP specimens, and only 50% (3/6) of normal pancreatic specimens were obtained. Taken together, we generated a total of 47 primary cultures with a success rate of 90.4% (47/51). These data suggest an association between the abundance of α-SMA-positive stromal cells present in pancreatic tissue and the likelihood that subsequent outgrowth cultures will be successful.
Outgrowth Cultures Demonstrate Phenotypes Consistent with Activated PSCs
Despite the pathologic diversity of surgical samples, outgrowth cultures of each specimen yielded morphologically identical fibroblastic, stellate-shaped cells (Figure 1c) . Immunofluorescent staining revealed abundant GFAP and α-SMA expression, biochemical markers of activated PSCs. In addition, outgrowths stained negative for ESA (Figure 2a) . This finding contrasts with immunohistochemical analysis of α-SMA expression in normal pancreatic tissue (Figure 1b) . These data suggest that quiescent PSCs in human tissue are initially activated in response to culture conditions, a phenomenon that has been previously described in PSCs as well as hepatic stellate cells. 9, 17 Taken together, primary PSCs isolated from normal pancreatic specimens were qualitatively indistinguishable from pancreatitis-and PC-derived PSCs in culture.
Flow cytometric analysis was then performed to further quantify cellular phenotypes. Population distributions revealed that 495% of cells in each stromal outgrowth expressed α-SMA with a subset expressing GFAP, consistent with current descriptions of PSC biology (Figure 2b) . 10 Less than 5% of stellate cell outgrowths demonstrated weak ESA positivity. Importantly, this pattern was not observed in commercially available HPF, which demonstrated o1% α-SMA-positivity and a higher proportion of ESA-positive cells. To determine if the ESA-positive population in primary outgrowths represented contaminating epithelial cells, this population was isolated by flow cytometric cell sorting and subsequently subcultured. The subcultures were phenotypically similar to the primary culture; these cells had stellate morphology and subsequently stained positive for α-SMA (Supplementary Figure 1) . Taken together, these data quantitatively confirm that primary pancreatic stromal outgrowths demonstrate phenotypes consistent with activated PSCs, lack epithelial contamination, and are in contrast with the observed phenotype of commercially available HPF.
Characteristic Phenotypes of PSCs in Culture
PSC outgrowth cultures demonstrated exponential growth in culture with limited proliferative capacity, consistently undergoing senescence between passages 8 and 10 ( Figure 3a) . Primary PSC cultures generated from normal pancreatic tissue (NAS) appeared to have less replicative potential with respect to CP (IAS) and PC (TAS), achieving average population doublings of 7.8 vs 10.3 and 10.1, respectively (Po0.05).
Vitamin A-containing lipid droplets represent an established hallmark of quiescent PSCs, a property that enables their isolation using a single density gradient method as described by Apte et al. 12 However, upon culture-induced activation, demonstrated by universal α-SMA expression, PSCs lose their vitamin A-containing lipid droplets. In order to determine whether PSC outgrowths retain plasticity with respect to activation state, adipocyte differentiation medium Pancreatic stellate cell primary cultures S Han et al (ADM) was employed in an attempt to drive cultured PSCs into a quiescent phenotype. Indeed, ADM administration led to cellular shrinking and the accumulation of perinuclear droplets, confirmed by Oil Red O staining to be lipid containing stores (Figure 3b) . In contrast to primary PSCs, the HPF cell line did not demonstrate these features despite ADM treatment. Culture-induced activation of PSCs therefore represents a potentially reversible process, suggesting the Flow cytometric analysis of α-SMA, GFAP, and ESA in pancreatic stromal outgrowths is displayed. DAPI, 4',6-Diamidino-2-Phenylindole; ESA, epithelial surface antigen; GFAP, glial fibrillary acidic protein; HPF, human pancreatic fibroblast; IAS, inflammation-associated stroma; NAS, normal-associated stroma; PC, pancreatic cancer; PSC, pancreatic stellate cell; TAS, tumor-associated stroma; α-SMA, α-smooth muscle actin.
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S Han et al maintenance of a certain extent of plasticity in primary cultured PSCs and modification of media conditions may prove an attractive method for the in vitro study of quiescent PSC biology.
Secretory Profiles of PSCs Are Independent of Donor Pancreatic Pathology
Emerging evidence implicates PSC activation in the pathogenesis of pancreatic disease states. 18, 19 However, the relationship between donor pancreatic pathology and PSC outgrowth biology remains unclear. Since the role of PSCs in pancreatic disease pathogenesis is often examined in the context of paracrine signaling, particularly with respect to inflammation, PSC biology was defined by soluble mediator secretory profiles in culture. Specifically, a panel of 41 secreted proteins including growth factors, chemokines, and cytokines were obtained from supernatants of representative NAS, IAS, and TAS outgrowths (Supplementary Table 1 ). These data demonstrate that PSC secretory profiles in culture do not differ significantly with respect to donor pancreatic pathology.
Secretory Profiles Change Over Time in Culture
We anticipated that PSC behavior evolves over time in culture, necessitating caution in the interpretation of experiments employing highly passaged PSCs. Indeed, PSC cultures demonstrated increased γ-H2AX expression coupled with decreased Ki-67 expression over time in culture (Figure 4b ). This pattern is consistent with the evolution of primary cells in culture, exhibiting limited replicative potential and eventually undergoing senescence. 20 Further, soluble mediator secretion profiles also evolved over time in culture. Interestingly, a predictable pattern emerged in that several cytokines, chemokines, and growth factors were secreted at higher concentrations in highly passaged PSCs (Figure 4c ). Specifically, concentrations of IL-6, IL-8, GRO, MCP-1, FGF-2, Fractalkine, IFN-α2, and MCP-3 were significantly elevated in late passages of multiple PSC outgrowth cultures, prompting caution when employing later passages for experimental use.
Co-Culture of PSCs with PC Cells Led to Consistent
Changes in Growth Factor, Cytokine, and Chemokine Secretion Emerging evidence suggests the importance of paracrine signaling between PC cells and PSCs in cancer progression. 21, 22 In order to evaluate the impact of paracrine communication between PSCs and PC cells, supernatants of PSC/PC co-culture experiments were analyzed. Primary PSC outgrowths were co-cultured with PC cell lines in a 10:1 ratio to emphasize the PSC contribution to the secretory profile. Co-culture in this manner led to increased concentrations of several growth factors, cytokines, and chemokines frequently implicated in pancreatic disease pathogenesis, including but not limited to FGF-2, G-CSF, IL-8, and RANTES ( Figure 5 and Supplementary Table S1 ). Importantly, no significant differences in soluble mediator profiles were observed between co-cultures employing different PC cell lines. Collectively, these data support the presence of complex interactions between primary PSCs and PC cells that can alter the pancreatic microenvironment during disease.
PSCs Augment Growth and Metastasis of PC Cells
In order to determine the functional significance of primary PSCs in PC engraftment and progression, we performed co-inoculations of tumor-associated PSCs with luciferasetransfected PC cells (L3.6pl-Luc). At an injection ratio of 1:100 L3.6pl-Luc PC cells to TAS cells, respectively, tumor growth was significantly augmented, as assessed using bioluminescence and tumor volume measurements (Figure 6a ). Further, in contrast to the central necrosis observed in control tumors, H&E sections of tumors from co-inoculated The application of ADM to PSCs was assessed using Oil Red O staining, demonstrating intracellular lipid stores. Images were visualized using the EVOS imaging system (×20 objective). ADM, adipogenic differentiation medium; GM, growth medium; HPF, human pancreatic fibroblast; IAS, inflammation-associated stroma; NAS, normal-associated stroma; PSC, pancreatic stellate cell; TAS, tumorassociated stroma.
Pancreatic stellate cell primary cultures S Han et al mice revealed a desmoplastic-rich architecture with pockets of viable areas centrally (Figure 6b ). Immediate bioluminescent imaging of explanted lungs demonstrated pulmonary metastasis in three of four (75%) PSC co-inoculated mice, which was additionally confirmed with H&E analysis (Figure 6c ). Metastatic lesions were absent in control mice. These results suggest a supportive, functional role of primary PSCs in the PC microenvironment.
DISCUSSION
The capacity to isolate and culture PSCs initiated a surge of research in pancreatic stromal biology, particularly in the context of the PC microenvironment. Limitations in the availability of pancreatic surgical specimens gave rise to the immortalization of PSCs. 23 Transformed PSC lines provided the additional benefit of eliminating potential confounders, such as variability between PSC isolation and culture practices. However, immortalization has been met with skepticism in the most recent PSC consensus conference. 10 In part, this work serves to validate those concerns and help standardize the approach to primary PSC isolation for in vitro and in vivo experimentation. Regardless of PSC donor pathology, we demonstrate consistent outgrowth phenotypes with respect to growth properties, onset of senescence, and expression of previously validated biomarkers. This consistency is further confirmed on analysis of soluble mediator secretion, suggesting insignificant differences in PSC outgrowth behavior with respect to donor pathology. We demonstrate that secretion patterns remain dynamic over time in culture, providing scientific support for the generally accepted practice of excluding highly passaged primary cells from investigation. Finally, consistent with previously published data incorporating PSCs into PC xenograft models, we demonstrate augmentation of tumor growth and metastasis upon co-inoculation with PC cells. Our data is consistent with previous reports exploring the functional aspects of PSCs in the PC microenvironment. 13, 24 We found an augmentation in tumor growth from the supplementation of PC cells with activated PSCs, and this finding is consistent with models incorporating similar primary PSC outgrowth cultures. 13, [25] [26] [27] Also consistent with our data, others have previously demonstrated augmented metastasis of tumors upon co-inoculation of PSCs with PC cells in murine xenograft models. 28 In contrast, stromal depletion strategies incorporated into genetically engineered mouse models of PC have recently provided data in opposition of this concept of activated PSCs supporting PC progression. 5, 6 However, it is also important to note that the modulation of PSC activation, rather than its elimination via prevention or conditional lethality, alleviated PC progression in work employing similar genetically engineered mouse models in PC. 9 This modulation suggests a contextdependent tumor-promoting role of activated PSCs. Our work therefore builds on similar investigations into PSC biology and expands upon current knowledge regarding human PSC isolation and functional characterization that will continue to be a vital consideration for further investigation into PC tumor-stromal interactions. The lack of variability in marker expression and secretion patterns with respect to donor pathology challenges the concept of a unique TAS phenotype. Erkan et al. 29 recently performed comprehensive gene expression profiles of PSC outgrowths from pancreatitis, PC, PC liver metastases and cirrhotic livers. Similarly, Pilarsky et al. 30 performed tissue microdissection of pancreatitis and PC samples and subsequent gene expression of stromal elements. Each of these Pancreatic stellate cell primary cultures S Han et al investigations reached the conclusion that stellate cell expression patterns differed between cancer and benign inflammation. Importantly, co-injection models have demonstrated that PSCs derived from nonmalignant pancreatic specimens augment PC growth and metastasis in a manner similar to TAS. 28 Regardless of function, genes implicated as cancer specific by these investigations were not analyzed in our experiments. We instead chose to focus on soluble mediators that may directly involve pathogenic paracrine signaling pathways, particularly in the development and maintenance of a chronic inflammatory state. Despite these identified differences in mRNA expression based on the underlying pathology from which these cells are isolated, our data would suggest that PSCs derived from malignant tissues should not be excluded as a potentially useful model for in vitro studies of human PSC biology in non-malignant disease states. In summary, we present data that suggest that isolation and expansion of human PSC using the outgrowth methodology from a diverse array of donor pathologies may serve as a source of primary cultures of activated and quiescent PSCs for in vitro and in vivo experimentation. This work provides a foundation for further investigation into the role of PSCs in the pathogenesis of pancreatic disease with enormous translational value.
